[Vendor] Homopeptide vs QSC on the same compound, same month, one test each
Trying to settle this properly because the thread from last year went in circles.
The claim: SURMOUNT matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 24 months without either producing anything.
What would actually settle it is 35 people measuring the same thing the same way. I have started; my numbers are below. They lean one way but not strongly enough for me to declare victory.
If you have data, post the data. If you have an opinion, flair it as an opinion.
best — the order this archive was captured in
Zepbound and Mounjaro are literally the same drug, the name is the only difference
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
do not crack the pen, we have been over this
I am going to push back on this slightly.
the dual agonism hits different and that is why people describe it differently
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
SURMOUNT data is messier than STEP data but the weight loss is there
do not crack the pen, we have been over this
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the GIP side does different things than the GLP-1 side, that is the point
Zepbound and Mounjaro are literally the same drug, the name is the only difference
Small correction: the trial was 17 weeks, not 15. Does not change your point but people will quote it.
Small correction: the trial was 17 weeks, not 15.
Yes, exactly this, and it is the bit that took me 23 weeks to accept.
- 1do not crack the pen, we have been over this6 comments in this branch · started by u/slow_logbook_ftw
- 2Zepbound and Mounjaro are literally the same drug, the name is the only…4 comments in this branch · started by u/titration_marshal